lexaptepid pegol
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01372137)
Timeline
Indications
Mechanism of action
- HepcidinINHIBITOR
HAMP inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4298061 ↗
Also known as
- lexaptepid pegol
- lexaptepid pegol
- lexaptepid pegol
- nox-h94
- nox-h94
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02079896 | Phase 1/Phase 2 (Phase 2) | May 1, 2014 | Noxxon AG |
| NCT01691040 | Phase 2 | Sep 1, 2012 | Noxxon AG |
| NCT01522794 | Phase 1 | Jan 1, 2012 | Noxxon AG, Radboud University |
| NCT01372137 | Phase 1 | Jul 1, 2011 | Noxxon AG |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Noxxon AG | For profit | 4 | 4 | 2 | 2011 |
| Radboud University | Academic/Hospital | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1